Hence, higher insulin secretion and downregulation of hepatic FOXO1 and its target genes in NASH‐HCC Spp1−/− mice could contribute to the beneficial effects of OPN deficiency on glucose metabolism, as also to the detrimental effect on hepatic lipid accumulation and toxicity. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatohepatitis.